You are viewing the public part of the archive. Login or request access to view more content.
Displaying 13-19 of 19 results
02:49:37
2012_24
Closing session of the XIX International AIDS Conference with speakers such as Bill Clinton, the two co-chairs of the conference Elly Katabira and Diane Havlir, US politician Nancy Pelosi, Françoise Barré-Sinoussi, and many activists and community leaders.
2012_24
01:12:17
2012_21
XIX International AIDS Conference in Washington D.C. Memory session of the AIDS activist Robert Carr, discussing discrimination of women, MSM, sex workers and drug users as well as people living with HIV/AIDS, and tributing Robert's work and friendship.
2012_21
00:43:45
2012_19
Opening press conference on the ending of AIDS at the XIX International AIDS Conference in Washington D.C. with congress woman Barbara Lee, the Director of IAS Elly Katabira, among others. A demonstration for the rights of sex workers and drug users takes place.
2012_19
01:05:00
2012_11
Opening ceremony of the Global Village at the XIX International AIDS Conference in Washington D.C. in 2012. Music performances and speeches by Michel Sidibé from UNAIDS, and others. Global Village is a section with representatives from civil society and HIV organizations.
2012_11
00:45:34
2012_10
XIX International AIDS Conference. Session on leadership and health policy with leaders of community networks in Russia and India, and the US governmental program PEPFAR. They answer questions on access to ARV treatment, housing and morphine for pain relief.
2012_10
00:19:27
2006_3_03
This is the third part of the interview with Dr Anthony Fauci. Here he talks about the American AIDS movement in the early 80's with activists such as the writer Larry Kramer in the frontline, and the time when he invited the leading activists up to his office.
2006_3_03
00:12:05
1994_40
Anthony Fauci is interviewed about the progression from HIV to AIDS. He talks about HIV long-term survivors and different aspects of non-progression to AIDS. He also reflects on the future for antiretroviral drugs and HIV vaccines.
1994_40






